Biodesix, Inc. (BDSX)

NASDAQ: BDSX · IEX Real-Time Price · USD
1.64
0.00 (0.00%)
At close: Jul 1, 2022 4:00 PM
1.56
-0.08 (-4.88%)
After-hours: Jul 1, 2022 7:16 PM EDT

Income Statement (Quarterly)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ended 2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Revenue
6.557.226.5311.8928.8727.039.194.245.18.273.94
Revenue Growth (YoY)
-77.32%-73.27%-28.96%180.37%466.44%226.79%133.21%----
Cost of Revenue
3.242.492.727.0918.2214.653.891.871.581.831.5
Gross Profit
3.314.733.814.810.6512.385.32.373.526.442.44
Selling, General & Admin
14.4913.5613.6111.4311.9312.067.886.838.086.568.21
Research & Development
3.212.853.293.323.323.112.712.112.92.52.36
Other Operating Expenses
0.080000000000
Operating Expenses
17.7716.4116.914.7515.2515.1710.598.9410.989.0610.57
Operating Income
-14.46-11.68-13.09-9.95-4.6-2.79-5.28-6.58-7.47-2.62-8.13
Interest Expense / Income
1.141.51.550.820.650.712.662.781.4610.71
Other Expense / Income
-0.010.11-3.120.641.711.040.9-1.090.782.90.76
Pretax Income
-15.59-13.28-11.51-11.4-6.96-4.53-8.85-8.27-9.71-6.53-9.6
Net Income
-15.59-13.28-11.51-11.4-6.96-4.53-8.85-8.27-9.71-6.53-9.6
Net Income Common
-15.59-13.28-11.51-11.4-6.96-4.53-8.85-8.27-9.71-6.53-9.6
Shares Outstanding (Basic)
3127282827500000
Shares Outstanding (Diluted)
3127282827500000
Shares Change
16.79%459.30%10026.72%9983.64%10093.10%1698.51%13.53%----
EPS (Basic)
-0.50-0.49-0.41-0.41-0.2693.21-31.93-30.06-37.18-23.10-39.35
EPS (Diluted)
-0.50-0.49-0.41-0.41-0.2693.21-31.93-30.06-37.18-23.10-39.35
Free Cash Flow Per Share
-0.43-0.40-0.320.03-0.45-1.92-18.36-16.29-17.93-22.87-26.06
Gross Margin
50.60%65.49%58.32%40.39%36.89%45.79%57.67%55.79%68.98%77.88%61.87%
Operating Margin
-220.85%-161.67%-200.44%-83.70%-15.94%-10.33%-57.47%-155.13%-146.49%-31.65%-206.29%
Profit Margin
-238.03%-183.86%-176.30%-95.94%-24.12%-16.77%-96.21%-195.00%-190.44%-78.89%-243.56%
Free Cash Flow Margin
-205.42%-150.03%-135.23%6.24%-41.02%-34.40%-55.33%-105.66%-91.82%-74.37%-161.31%
EBITDA
-13.26-10.93-9.17-9.81-5.56-3.1-5.4-4.77-7.57-4.81-8.2
EBITDA Margin
-202.52%-151.31%-140.38%-82.54%-19.28%-11.46%-58.78%-112.50%-148.55%-58.14%-207.94%
Depreciation & Amortization
1.190.860.80.780.750.730.780.710.680.710.7
EBIT
-14.45-11.79-9.97-10.59-6.31-3.83-6.19-5.48-8.25-5.52-8.9
EBIT Margin
-220.66%-163.15%-152.63%-89.08%-21.86%-14.16%-67.30%-129.32%-161.85%-66.76%-225.65%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).